Changes of KEAP1/NRF2 and IKB/NF-κB Expression Levels Induced by Cell-Free DNA in Different Cell Types. (20th March 2018)

• Record Type: Journal Article
• Authors: Kostyuk, Svetlana V.; Porokhovnik, Lev N.; Ershova, Elizaveta S.; Malinovskaya, Elena M.; Konkova, Marina S.; Kameneva, Larisa V.; Dolgikh, Olga A.; Veiko, Vladimir P.; Pisarev, Vladimir M.; Martynov, Andrew V.; Sergeeva, Vasilina A.; Kaliyanov, Andrew A.; Filev, Anton D.; Chudakova, Julia M.; Abramova, Margarita S.; Kutsev, Serguey I.; Izhevskaya, Vera L.; Veiko, Nataliya N.
• Other Names: Büttner Sabrina Academic Editor.
• Is Part Of: Oxidative medicine and cellular longevity. Volume 2018(2018)
• Publication Date: 2018-03-20
• Subjects: Oxidative stress -- Periodicals; Cells -- Aging -- Periodicals; Cells -- Aging; Oxidative stress; Oxidative Stress -- Periodicals; Cell Aging -- Periodicals; Periodicals; 611.0181
• DOI: 10.1155/2018/1052413
• Languages: English
• ISSNs: 1942-0900

Abstract

Abstract : Cell-free DNA (cfDNA) is a circulating DNA of nuclear and mitochondrial origin mainly derived from dying cells. Recent studies have shown that cfDNA is a stress signaling DAMP (damage-associated molecular pattern) molecule. We report here that the expression profiles of cfDNA-induced factors NRF2 and NF- κ B are distinct depending on the target cell's type and the GC-content and oxidation rate of the cfDNA. Stem cells (MSC) have shown higher expression of NRF2 without inflammation in response to cfDNA. In contrast, inflammatory response launched by NF- κ B was dominant in differentiated cells HUVEC, MCF7, and fibroblasts, with a possibility of transition to massive apoptosis. In each cell type examined, the response for oxidized cfDNA was more acute with higher peak intensity and faster resolution than that for nonoxidized cfDNA. GC-rich nonoxidized cfDNA evoked a weaker and prolonged response with proinflammatory component (NF- κ B) as predominant. The exploration of apoptosis rates after adding cfDNA showed that cfDNA with moderately increased GC-content and lightly oxidized DNA promoted cell survival in a hormetic manner. Novel potential therapeutic approaches are proposed, which depend on the current cfDNA content: either preconditioning with low doses of cfDNA before a planned adverse impact or eliminating (binding, etc.) cfDNA when its content has already become high.